Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III

. 2009 Aug ; 276 (16) : 4448-62.

Jazyk angličtina Země Anglie, Velká Británie Médium print

Typ dokumentu časopisecké články, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/pmid19678840

Grantová podpora
Intramural NIH HHS - United States

Glutamate carboxypeptidase III (GCPIII) is a metalloenzyme that belongs to the transferrin receptor/glutamate carboxypeptidase II (GCPII; EC 3.4.17.21) superfamily. GCPIII has been studied mainly because of its evolutionary relationship to GCPII, an enzyme involved in a variety of neuropathologies and malignancies, such as glutamatergic neurotoxicity and prostate cancer. Given the potential functional and pharmacological overlap between GCPIII and GCPII, studies addressing the structural and physiological properties of GCPIII are crucial for obtaining a deeper understanding of the GCPII/GCPIII system. In the present study, we report high-resolution crystal structures of the human GCPIII ectodomain in a 'pseudo-unliganded' state and in a complex with: (a) L-glutamate (a product of hydrolysis); (b) a phosphapeptide transition state mimetic, namely (2S,3'S)-{[(3'-amino-3'-carboxy-propyl)-hydroxyphosphinoyl]methyl}-pentanedioic acid; and (c) quisqualic acid, a glutamate biostere. Our data reveal the overall fold and quaternary arrangement of the GCPIII molecule, define the architecture of the GCPIII substrate-binding cavity, and offer an experimental evidence for the presence of Zn(2+) ions in the bimetallic active site. Furthermore, the structures allow us to detail interactions between the enzyme and its ligands and to characterize the functional flexibility of GCPIII, which is essential for substrate recognition. A comparison of these GCPIII structures with the equivalent GCPII complexes reveals differences in the organization of specificity pockets, in surface charge distribution, and in the occupancy of the co-catalytic zinc sites. The data presented here provide information that should prove to be essential for the structurally-aided design of GCPIII-specific inhibitors and might comprise guidelines for future comparative GCPII/GCPIII studies.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase Inhibitors

. 2024 Feb 12 ; 64 (3) : 1030-1042. [epub] 20240115

Uncovering the essential roles of glutamate carboxypeptidase 2 orthologs in Caenorhabditis elegans

. 2024 Jan 31 ; 44 (1) : .

Characterization of glutamate carboxypeptidase 2 orthologs in trematodes

. 2022 Dec 20 ; 15 (1) : 480. [epub] 20221220

Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer

. 2020 Nov 04 ; 48 (19) : 11130-11145.

Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors

. 2019 Jan 15 ; 27 (2) : 255-264. [epub] 20181114

The calcium-binding site of human glutamate carboxypeptidase II is critical for dimerization, thermal stability, and enzymatic activity

. 2018 Sep ; 27 (9) : 1575-1584.

Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools

. 2017 May ; 77 (7) : 749-764. [epub] 20170301

DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening

. 2017 Jan 25 ; 45 (2) : e10. [epub] 20160926

Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II

. 2014 Jul ; 281 (14) : 3228-42. [epub] 20140617

Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer

. 2012 ; 19 (6) : 856-70.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...